MedPath

Emeramide

Generic Name
Emeramide
Drug Type
Small Molecule
Chemical Formula
C12H16N2O2S2
CAS Number
351994-94-0
Unique Ingredient Identifier
4U7K5X4ANS

Overview

Emeramide has been used in trials studying the treatment of Mercury Poisoning.

Background

Emeramide has been used in trials studying the treatment of Mercury Poisoning.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
Phase 2
Completed
Posted: 2019/09/17
Sponsor:
EmeraMed
ID:NCT04092205
NBMI - Clinical Study on COPD
Phase 2
Completed
Posted: 2017/04/21
Sponsor:
EmeraMed
ID:NCT03123692
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
Phase 2
Completed
Posted: 2015/07/01
Sponsor:
EmeraMed
ID:NCT02486289

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy